seminars:datasci:021423
Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
| seminars:datasci:021423 [2023/02/03 20:34] – created gfu | seminars:datasci:021423 [2023/02/03 20:35] (current) – gfu | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | <WRAP centeralign>## | ||
| + | |||
| + | * Date: Tuesday, February 14, 2023 | ||
| + | * Time: 12:00pm -- 1:00pm | ||
| + | * Room: Whitney Hall 100E | ||
| + | * Speaker: Dr. Yuan Fang (Binghamton University) | ||
| + | * Title: Clustering disease trajectories: | ||
| + | |||
| + | <WRAP center box 80%> | ||
| + | <WRAP centeralign> | ||
| + | \\ | ||
| + | Biological and medical data increasingly have high dimensionality and complicated | ||
| + | structures. Cluster analysis is a common exploratory analysis technique for identifying | ||
| + | the underlying latent classes in a dataset. For many diseases, the underlying | ||
| + | pathophysiology is complex, and heterogeneity in the natural history of the disease is | ||
| + | common. Clustering the trajectories of disease progression can be helpful in | ||
| + | understanding observed variability. In this talk, I will discuss the applications and | ||
| + | evaluation of cluster analysis for identifying heterogeneity in longitudinal trajectories | ||
| + | using a latent class mixed effect model (LCMM) approach. I will start with two examples | ||
| + | of applying LCMM to identify latent patterns in trajectories: | ||
| + | applied LCMM and identified clinically meaningful subgroups in the disease progression | ||
| + | of Duchenne muscular dystrophy; b) I will present preliminary results from our current | ||
| + | study on the heterogeneity in trajectories of cognitive status, measured by a more | ||
| + | complex outcome set, in participants from the community-based Framingham Heart | ||
| + | Study. Then, I will show how to use simulation studies to evaluate the ability of LCMMs | ||
| + | to accurately classify individuals for a wide range of noise and variability in trajectories | ||
| + | and to provide guidelines for model specification when using this technique. | ||
| + | \\ | ||
| + | |||
| + | |||
| + | Biography of the speaker: Dr. Fang joined the Department of Pharmaceutical Sciences at Binghamton University in 2023. She received her Ph.D. in Mathematics and Statistics with a focus on Statistics from Binghamton University Department of Mathematical Sciences under the guidance of Dr. Sanjeena Dang. Her Ph.D. research | ||
| + | mainly focused on developing novel unsupervised learning algorithms for non-standard data types that | ||
| + | are usually encountered in biomedical research. Following her graduate studies, Yuan joined the group | ||
| + | of Drs. Kathryn Lunetta and Joanne Murabito at Boston University School of Public Health as a | ||
| + | postdoctoral associate. Her postdoc research focused on applying statistical tools to investigate the | ||
| + | association between circulating immune cell phenotypes in the pro-inflammatory and regulatory | ||
| + | pathways with cognitive decline, dementia, and Alzheimer’s disease. She has also been working on | ||
| + | quantifying the heterogeneity in decline trajectories of cognitive functions in the Framingham Heart | ||
| + | Study participants. Yuan’s current research focuses on studying lipid profiles for ceramide pathways in | ||
| + | boys with Duchenne Muscular Dystrophy using multi-omics statistical and bioinformatics approaches. | ||
| + | She is also interested in extending existing models and statistical approaches to clustering omics data | ||
| + | and longitudinal data. | ||
| + | |||
| + | </ | ||
